Risk factor
High price volatility
Profitability factor
Very favourable analyst view
About
LigaChem Biosciences, Inc. specializes in the development and manufacturing of a broad spectrum of medical solutions, encompassing pharmaceuticals, medical devices, and essential healthcare supplies. Their extensive product offerings include various therapeutic agents such as antibiotics, anti-coagulants, and oncology treatments, alongside cutting-edge antibody-drug conjugates and protein-drug conjugates. Established on May 2, 2006, the company's headquarters are situated in Daejeon, South Korea.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of 141080.KQ is 226781 and suggests 69.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation